Cancer Family
Hematopoietic and Lymphatic System Neoplasm
CI-CAN-00000022Explore in graph →
Non-malignant4,304 active trials98 approved drugs1,010 evidence items
- NCIt
- C35813
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000022Explore in graph →
Clinical trials
18,827 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00003661 | Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer | completed | Phase 2 | 3 | Roswell Park Cancer InstituteOTHER | 1 | Mar 7, 2011 | clinicaltrials |
| NCT00003662 | Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases | completed | Phase 2 | 90 | Roswell Park Cancer InstituteOTHER | 1 | Mar 7, 2011 |
| NCT00055653 | Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders | completed | Phase 2 | — | Roswell Park Cancer InstituteOTHER | 1 | Mar 7, 2011 | clinicaltrials |
| NCT00646139 | KX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to Treatment | completed | Phase 1 | 7 | Roswell Park Cancer InstituteOTHER | 1 | Mar 2, 2011 | clinicaltrials |
| NCT00053118 | Chemotherapy and Stem Cell Transplantation in Treating Children With Central Nervous System Cancer | completed | Phase 1 | 1 | Roswell Park Cancer InstituteOTHER | 1 | Mar 1, 2011 | clinicaltrials |
| NCT00983138 | Efficacy and Safety of Recombinant Asparaginase in Infants With Previously Untreated Acute Lymphoid Leukemia (ALL) | completed | Phase 2 | 12 | medac GmbHINDUSTRY | 2 | Mar 1, 2011 | clinicaltrials |
| NCT00481858 | Kinetic Biomarker for Chronic Lymphocytic Leukemia Prognosis(CRC011) | completed | — | 150 | KineMedINDUSTRY | 1 | Feb 28, 2011 | clinicaltrials |
| NCT00004875 | Heparin or Enoxaparin in Patients With Cancer | completed | — | 6 | Northwestern UniversityOTHER | 1 | Feb 21, 2011 | clinicaltrials |
| NCT00005619 | Analysis of Blood and Bone Marrow to Detect Residual Disease in Patients With Previously Treated Hairy Cell Leukemia | completed | — | 16 | Northwestern UniversityOTHER | 1 | Feb 21, 2011 | clinicaltrials |
| NCT00248443 | Réa-MiniMax: Severe Acute Respiratory Failure in Hematology and Cancer Patients Without Bronchoalveolar Lavage | completed | Phase 3 | 206 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Feb 18, 2011 | clinicaltrials |
| NCT00772811 | Using Fludarabine and Melphalan Conditioning Regimen for CLL,Lymphoma,Multiple Myeloma(Flu-Mel) | completed | Phase 2 | 38 | Cooperative Study Group A for HematologyNETWORK | 1 | Feb 17, 2011 | clinicaltrials |
| NCT01296503 | Thalidomide Plus Dexamethasone as Maintenance Therapy for Multiple Myeloma | completed | Phase 3 | 213 | Grupo de Estudos Multicentricos em Onco-HematologiaNETWORK | 1 | Feb 15, 2011 | clinicaltrials |
| NCT00185653 | Mixed Chimera Allogeneic Transplantation From Matched Unrelated Donors For The Treatment Of Multiple Myeloma | completed | N/A | 40 | Stanford UniversityOTHER | 1 | Feb 14, 2011 | clinicaltrials |
| NCT00774280 | Busulfan Plus Cyclophosphamide vs Fludarabine as a Conditioning Regimen(BuCyvsBUFlu) | completed | Phase 3 | 130 | Cooperative Study Group A for HematologyNETWORK | 1 | Feb 14, 2011 | clinicaltrials |
| NCT00274807 | Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia | completed | Phase 2 | 40 | The Cleveland ClinicOTHER | 0 | Feb 11, 2011 | clinicaltrials |
| NCT00602511 | Thalidomide Versus Bortezomib in Melphalan Refractory Myeloma | completed | Phase 3 | 300 | Nordic Myeloma Study GroupOTHER | 3 | Feb 9, 2011 | clinicaltrials |
| NCT00285103 | SPC2996 in Chronic Lymphocytic Leukaemia | completed | Phase 1 / Phase 2 | 46 | Santaris Pharma A/SINDUSTRY | 4 | Feb 2, 2011 | clinicaltrials |
| NCT00354146 | A Phase 2 Study of Farnesyl Transferase Inhibitor (R115777, Tipifarnib) in Patients With Refractory or Relapsed Acute Myeloid Leukemia. | completed | Phase 2 | 252 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 0 | Feb 1, 2011 | clinicaltrials |
| NCT00509379 | Non-randomized Safety Study With Bortezomib/Rituximab in Relapsed/Refractory Indolent Lymphoma(LYM-2023) | completed | Phase 2 | 48 | Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle LeucemieOTHER | 1 | Jan 28, 2011 | clinicaltrials |
| NCT00987987 | Amplifying Graft-Versus-Tumor Effect by Donor Regulatory T-Cell Depletion Before Donor Lymphocytes Infusion(ILD-Treg) | completed | Phase 1 / Phase 2 | 21 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Jan 24, 2011 | clinicaltrials |
| NCT00502385 | Phase I AZD2171 in Patients With Relapsed or Refractory AML and Elderly Patients With DeNovo or Secondary AML | completed | Phase 1 | 54 | AstraZenecaINDUSTRY | 0 | Jan 21, 2011 | clinicaltrials |
| NCT01054937 | Single Dose Study With 4SC-203 in Healthy Volunteers | completed | Phase 1 | 60 | 4SC AGINDUSTRY | 1 | Jan 13, 2011 | clinicaltrials |
| NCT00388635 | Velcade-Melphalan-Prednisone in Older Untreated Multiple Myeloma Patients. | completed | Phase 1 / Phase 2 | 60 | PETHEMA FoundationOTHER | 1 | Jan 11, 2011 | clinicaltrials |
| NCT01274403 | A Randomized Study With Oral Melphalan + Prednisone (MP) Versus Melphalan, + Prednisone + Thalidomide (MPT) for Newly Diagnosesd Elderly Patients With Multiple Myeloma | completed | Phase 2 | 130 | Gruppo Italiano Studio LinfomiOTHER | 1 | Jan 11, 2011 | clinicaltrials |
| NCT00003269 | Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors | completed | Phase 2 | 20 | Scripps HealthOTHER | 1 | Jan 10, 2011 | clinicaltrials |
| NCT00193440 | Rituximab and Chemotherapy Followed by Ibritumomab Tiuxetan as Treatment for Low Grade Follicular Non-Hodgkin's Lymphoma | completed | Phase 2 | 40 | SCRI Development Innovations, LLCOTHER | 0 | Dec 30, 2010 | clinicaltrials |
| NCT00193466 | Rituximab and Fludarabine Followed by CAMPATH-1H in Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | completed | Phase 2 | 40 | SCRI Development Innovations, LLCOTHER | 0 | Dec 30, 2010 | clinicaltrials |
| NCT00358072 | Treatment of Adult ALL With an MRD-directed Programme. | completed | Phase 2 | 280 | Northern Italy Leukemia GroupOTHER | 1 | Dec 29, 2010 | clinicaltrials |
| NCT00787384 | Efficacy of Imatinib Mesylate in Hypereosinophilic Syndromes(NILG-HES1-03) | completed | Phase 2 | 25 | Northern Italy Leukemia GroupOTHER | 1 | Dec 29, 2010 | clinicaltrials |
| NCT00271050 | External Beam Radiotherapy and Zevalin for Management of Indolent B-Cell Non-Hodgkin's Lymphoma | completed | Phase 1 | 12 | The Cleveland ClinicOTHER | 1 | Dec 21, 2010 | clinicaltrials |
| NCT01021358 | A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-263 (Navitoclax). | completed | Phase 1 | 12 | AbbottINDUSTRY | 1 | Dec 20, 2010 | clinicaltrials |
| NCT00482703 | A Study of Dasatinib in Chronic Phase Philadelphia Chromosome Positive Chronic Myeloid Leukemia | completed | Phase 1 / Phase 2 | 23 | Bristol-Myers SquibbINDUSTRY | 1 | Dec 17, 2010 | clinicaltrials |
| NCT01030718 | Rollover Study of BMS-354825 in Patients With CML and Ph+ALL | completed | Phase 1 / Phase 2 | 54 | Bristol-Myers SquibbINDUSTRY | 0 | Dec 14, 2010 | clinicaltrials |
| NCT00497991 | Safety, Tolerability, PK and Efficacy of AZD1152 in Patients With Relapsed Acute Myeloid Leukemia | completed | Phase 1 | 65 | AstraZenecaINDUSTRY | 4 | Dec 8, 2010 | clinicaltrials |
| NCT01248000 | The Use of FDG-PET in Patient With Hodgkin Lymphoma: a Population Based Study From Northern Italy | completed | — | 136 | Gruppo Italiano Studio LinfomiOTHER | 1 | Nov 25, 2010 | clinicaltrials |
| NCT01247493 | Modified-FLAI Induction and Consolidation Chemotherapy in Elderly Patient With Acute Myeloid Leukemia (AML)(m-FLAI) | completed | Phase 2 | 108 | Seoul National University HospitalOTHER | 1 | Nov 24, 2010 | clinicaltrials |
| NCT01015261 | Allogenic Bone Marrow Transplantation (BMT) Compare With Cytoreduction and Chemotherapy in Acute Lymphoblastic Leukemia (ALL) Patients | completed | Phase 2 / Phase 3 | 30 | Tehran University of Medical SciencesOTHER | 1 | Nov 22, 2010 | clinicaltrials |
| NCT01234129 | Stem Cell Transplant and Zoledronic Acid Improve Outcome in Previously Untreated Patients With Multiple Myeloma | completed | — | 320 | Instituto Mexicano del Seguro SocialOTHER_GOV | 1 | Nov 4, 2010 | clinicaltrials |
| NCT01233895 | Study of AVE1642 Anti-IGF1R Monoclonal Antibody in Patients With Advanced Multiple Myeloma | completed | Phase 1 | 26 | SanofiINDUSTRY | 2 | Nov 3, 2010 | clinicaltrials |
| NCT00095680 | Extension Study of the Efficacy and Safety of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple Myeloma | completed | Phase 2 | 30 | Scios, Inc.INDUSTRY | 0 | Oct 22, 2010 | clinicaltrials |
| NCT00689000 | Safety and Anti-Disease Activity of CHR-2797 (Tosedostat) in Elderly and/or Treatment Refractory Patients With Acute Myeloid Leukemia (AML) and Multiple Myeloma (MM) | completed | Phase 1 / Phase 2 | 57 | Chroma TherapeuticsINDUSTRY | 1 | Oct 22, 2010 | clinicaltrials |
| NCT01019161 | An Open Label, Single Centre Mass Balance C14 Study in Patients With Acute Myeloid Leukaemia (AML) | completed | Phase 1 | 5 | AstraZenecaINDUSTRY | 1 | Oct 20, 2010 | clinicaltrials |
| NCT00087867 | Study of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple Myeloma | completed | Phase 2 | 62 | Scios, Inc.INDUSTRY | 0 | Oct 18, 2010 | clinicaltrials |
| NCT00713505 | Educational and Skills Training Program for Parents of Childhood Cancer Survivors Who Have Neurobehavioral Dysfunction | completed | N/A | 56 | City of Hope Medical CenterOTHER | 1 | Oct 13, 2010 | clinicaltrials |
| NCT00186290 | Allo BMT in Advanced Leukemia or High Grade Lymphoma | completed | N/A | 145 | Stanford UniversityOTHER | 1 | Oct 11, 2010 | clinicaltrials |
| NCT00743028 | Assess the Oral Bioavailability of New ABT-263 Formulations | completed | Phase 1 | 36 | AbbottINDUSTRY | 1 | Oct 7, 2010 | clinicaltrials |
| NCT00002510 | Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma | completed | Phase 1 / Phase 2 | — | Temple UniversityOTHER | 1 | Oct 1, 2010 | clinicaltrials |
| NCT00002521 | Combination Chemotherapy and Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma | completed | Phase 2 | — | Temple UniversityOTHER | 1 | Oct 1, 2010 | clinicaltrials |
| NCT00002522 | Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma | completed | Phase 2 | — | Temple UniversityOTHER | 1 | Oct 1, 2010 | clinicaltrials |
Data updated 23 days agoSource updated Mar 7, 2011source: clinicaltrials